Critical Care Medicine Doctors in Portland, ME Accepting Medicare

5 Critical Care Medicine doctors found. Showing 1 - 5

Dr. Joseph Foley Scrobola, D.O. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 Fore River Pkwy, Portland, ME 04102 Phone: 207-553-6105

Steven A Hess, MD Internal Medicine - Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 22 Bramhall St., Portland, ME 04102 Phone: 207-662-4618    Fax: 207-662-6254

Sandra Bagwell, MD Internal Medicine - Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-2179    Fax: 207-662-6326

Stuart Maxson Weymouth, PA-C Internal Medicine - Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-0111

Dr. Heidi Frutchy Deblock, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-4618

News Archive

Breakthrough research discovers new way to slow progression of diabetic kidney disease

With World Diabetes Day (14th November) on the horizon new breakthrough research from Monash University has discovered a way to slow the progression of kidney disease in people with diabetes.

Research shows how colanic acid extends lifespan in C. elegans

Baylor College of Medicine researcher Meng Wang had already shown that bacteria that make a metabolite called colanic acid (CA) could extend the lifespan of worms in her lab by as much as 50%, but her collaboration with Rice University synthetic biologist Jeffrey Tabor is providing tools to answer the bigger question of how the metabolite imparts longer life.

New silver coated anti-microbial barrier dressing receives Canadian approval

NUCRYST Pharmaceuticals, a developer and manufacturer of medical products that fight infection and inflammation, and the Advanced Wound Management division of Smith & Nephew plc announced today that Health Canada granted marketing approval for Acticoat Flex barrier dressing for wounds that require up to seven days of sustained antimicrobial activity.

Study shows gender differences in prognosis predictive utility of breast cancer recurrence score

The TAILORx study published last year offered good news for women with early-stage ER-positive breast cancer who scored at intermediate risk for recurrence according to a genetic assay test.

Gilead to resolve Viread patent litigation case with Teva

Gilead Sciences, Inc. today announced that Gilead and Teva Pharmaceuticals have reached an agreement in principle to settle the ongoing patent litigation concerning the patents protecting Viread (tenofovir disoproxil fumarate), a treatment for HIV infection and chronic hepatitis B. Under the terms of the settlement, Teva will be allowed to launch a generic version of Viread on December 15, 2017.

Read more Medical News

› Verified 1 days ago